Treatment-free remission in patients with chronic myeloid leukemia: literature review
Tyrosine kinase inhibitors have radically changed the course of chronic myeloid leukemia, significantly increasing survival and reducing the risk of disease progression. Nearly 50–70 % of patients achieve a consistently low or undetectable level of minimal residual disease – a deep molecular respons...
Saved in:
| Main Authors: | A. N. Petrova, E. Yu. Chelysheva, A. G. Turkina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2019-10-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/367 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Eligibility for treatment-free remission among chronic myeloid leukemia patients in Iraqi Kurdistan region
by: Haydar Hasan Darwes, et al.
Published: (2025-01-01) -
Management of Chronic Myeloid Leukemia Patients During Pregnancy (Analysis of Literature and Practical Recommendations)
by: EYu Chelysheva, et al.
Published: (2019-03-01) -
Treatment of Chronic Myeloid Leukemia According to Current Guidelines: The Results of the Pilot Prospective Study “Early Induction Therapy and Monitoring” (РИТМ)
by: OA Shukhovv, et al.
Published: (2019-03-01) -
Clinical Recommendations for the Diagnosis and Treatment of Chronic Myeloid Leukemia
by: AG Turkina, et al.
Published: (2017-07-01) -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
by: Michele Baccarani, et al.
Published: (2014-01-01)